Literature DB >> 2091932

Study design and description of patients.

P Lutz1, H Schmidt, U Batzler.   

Abstract

A West German multicentre study (eight centres) of PKU was designed in 1976. The subjects of the study are the differential diagnosis, factors influencing the therapeutic outcome, and the extension of dietary therapy into adolescence. Between 1978 and 1984, 165 patients were enrolled, of whom 38 were of non-German nationality. The educational and occupational status of the West German parents were comparable to the population of the Federal Republic of Germany. In the central data bank located at the University Childrens Hospital in Heidelberg, data from recurrent medical examinations and from biochemistry, dietetics, neurology, psychometry and demography were collected. The differential diagnosis of the elevated plasma Phe level in the newborn period resulted in the detection of 2 patients with a PTPS-deficiency, and of 163 with an apo-enzyme defect. Depending upon the magnitude of the Phe levels during the first weeks of life, preliminary treatment groups were formed. They were revised at the age of 6 months with a protein challenge. The levels of Phe during the protein challenge resulted in three types of response. Of these, type III can apparently forgo dietary restrictions resulting in plasma Phe concentrations of around 10 mg/dl. Preliminary results of the whole study are now presented.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2091932     DOI: 10.1007/BF02126292

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  22 in total

1.  A SIMPLE PHENYLALANINE METHOD FOR DETECTING PHENYLKETONURIA IN LARGE POPULATIONS OF NEWBORN INFANTS.

Authors:  R GUTHRIE; A SUSI
Journal:  Pediatrics       Date:  1963-09       Impact factor: 7.124

Review 2.  Molecular basis and population genetics of phenylketonuria.

Authors:  S L Woo
Journal:  Biochemistry       Date:  1989-01-10       Impact factor: 3.162

Review 3.  Inborn errors of pterin metabolism.

Authors:  N Blau
Journal:  Annu Rev Nutr       Date:  1988       Impact factor: 11.848

4.  Molecular biology of phenylketonuria.

Authors:  F Güttler; A G DiLella; F D Ledley; A S Lidsky; S C Kvok; J Marvit; S L Woo
Journal:  Eur J Pediatr       Date:  1987       Impact factor: 3.183

5.  Results of psychological testing of patients aged 3-6 years.

Authors:  U Michel; E Schmidt; U Batzler
Journal:  Eur J Pediatr       Date:  1990       Impact factor: 3.183

6.  Six-year follow up of phenylalanine intakes and plasma phenylalanine concentrations.

Authors:  U Wendel; K Ullrich; H Schmidt; U Batzler
Journal:  Eur J Pediatr       Date:  1990       Impact factor: 3.183

7.  Significance of the in vivo deuterated phenylalanine load for long-term phenylalanine tolerance and psycho-intellectual outcome in patients with PKU.

Authors:  F K Trefz; U Batzler; T König; U Michel; E Schmidt; H Schmidt; H Bickel
Journal:  Eur J Pediatr       Date:  1990       Impact factor: 3.183

8.  EEG development in early treated PKU patients from birth to 6 years of age.

Authors:  J Pietz; A Lütcke; D Sontheimer; C Benninger; B Pietz; U Batzler; A Heusser
Journal:  Eur J Pediatr       Date:  1990       Impact factor: 3.183

9.  Correlation between polymorphic DNA haplotypes at phenylalanine hydroxylase locus and clinical phenotypes of phenylketonuria.

Authors:  F Güttler; F D Ledley; A S Lidsky; A G DiLella; S E Sullivan; S L Woo
Journal:  J Pediatr       Date:  1987-01       Impact factor: 4.406

10.  [Differential diagnosis of increased phenylalanine blood level in infancy. Results of the German collaborative study on phenylketonuria (PKU)/hyperphenylalaninemia (HPA)].

Authors:  H Schmidt; P Lutz; U Batzler
Journal:  Monatsschr Kinderheilkd       Date:  1989-02       Impact factor: 0.323

View more
  11 in total

1.  Development of Metabolic Phenotype in Phenylketonuria: Evaluation of the Blaskovics Protein Loading Test at 5 Years of Age.

Authors:  P Burgard; E Mönch; J Zschocke; U Wendel; U Langenbeck
Journal:  JIMD Rep       Date:  2015-12-19

2.  Relation between phenylalanine hydroxylase genotypes and phenotypic parameters of diagnosis and treatment of hyperphenylalaninaemic disorders. German Collaborative Study of PKU.

Authors:  U Lichter-Konecki; A Rupp; D S Konecki; F K Trefz; H Schmidt; P Burgard
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

3.  Results of psychological testing of patients aged 3-6 years.

Authors:  U Michel; E Schmidt; U Batzler
Journal:  Eur J Pediatr       Date:  1990       Impact factor: 3.183

4.  Significance of the in vivo deuterated phenylalanine load for long-term phenylalanine tolerance and psycho-intellectual outcome in patients with PKU.

Authors:  F K Trefz; U Batzler; T König; U Michel; E Schmidt; H Schmidt; H Bickel
Journal:  Eur J Pediatr       Date:  1990       Impact factor: 3.183

Review 5.  Inherited metabolic diseases affecting the carrier.

Authors:  W Endres
Journal:  J Inherit Metab Dis       Date:  1997-03       Impact factor: 4.982

6.  Metabolic phenotypes of phenylketonuria. Kinetic and molecular evaluation of the Blaskovics protein loading test.

Authors:  U Langenbeck; P Burgard; U Wendel; M Lindner; J Zschocke
Journal:  J Inherit Metab Dis       Date:  2009-07-16       Impact factor: 4.982

7.  Blood phenylalanine concentrations in patients with PAH-deficient hyperphenylalaninaemia off diet without and with three different single oral doses of tetrahydrobiopterin: assessing responsiveness in a model of statistical process control.

Authors:  M Lindner; G Gramer; S F Garbade; P Burgard
Journal:  J Inherit Metab Dis       Date:  2009-06-10       Impact factor: 4.982

8.  Intellectual development of the patients of the German Collaborative Study of children treated for phenylketonuria.

Authors:  P Burgard; E Schmidt; A Rupp; W Schneider; H J Bremer
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

9.  Phenylalanine hydroxylase genotypes, predicted residual enzyme activity and phenotypic parameters of diagnosis and treatment of phenylketonuria.

Authors:  P Burgard; A Rupp; D S Konecki; F K Trefz; H Schmidt; U Lichter-Konecki
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

10.  Pharmacokinetics of tetrahydrobiopterin following oral loadings with three single dosages in patients with phenylketonuria.

Authors:  G Gramer; S F Garbade; N Blau; M Lindner
Journal:  J Inherit Metab Dis       Date:  2008-11-21       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.